NASDAQ:ASPX (ASPX) (ASPX) Stock Price, News & Analysis → Trump’s last act as President (From Porter & Company) (Ad) Free ASPX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume1.02 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (ASPX) alerts: Email Address Ad Porter & CompanyTrump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. About (ASPX) Stock (NASDAQ:ASPX)Auspex Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for people with movement disorders and other rare diseases, including orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea (abnormal involuntary movements) associated with Huntington's disease, an orphan disease, tardive dyskinesia and Tourette syndrome in the pediatric population, which is an orphan disease, as well as other orphan indications. Its lead product candidate is SD-809, which is a small molecule inhibitor of vesicular monoamine transporter 2 (VMAT2). Its other programs include SD-560, SD-1077 and SD-254.Read More Ad Porter & CompanyTrump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. ASPX Stock News HeadlinesApril 29, 2024 | markets.businessinsider.comCloud DX Reports FY2023 ResultsApril 29, 2024 | msn.comOdessa’s boil water notice has been removedApril 30, 2024 | Porter & Company (Ad)Trump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. April 29, 2024 | yahoo.comLooking for Mother's Day brunch in Peoria? Here's a long list of local restaurant optionsApril 29, 2024 | msn.comStudy reveals high levels of antibiotic resistance in meat sold for consumptionApril 28, 2024 | msn.com'No Mow' May, rain gardens and more support Oakland County pollinatorsApril 28, 2024 | yahoo.comParents, students faced with switching schools. Clovis approves new attendance boundariesApril 28, 2024 | msn.comWhat to know about riding an electric bicycle in Erie, Millcreek or at Presque IsleApril 30, 2024 | Porter & Company (Ad)Trump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. April 28, 2024 | msn.comHave you been to this historic garden in Central Jersey? | Gardener StateApril 28, 2024 | msn.comCivic calendar | Arcata will discuss hiring a retired city workerApril 27, 2024 | msn.comPET brain scans could reveal hidden inflammation in patients with multiple sclerosisApril 27, 2024 | msn.com'Constant terror' in Rafah as Palestinians brace for Israeli invasionApril 27, 2024 | news.yahoo.comElection 2024: Q&A with state representative candidate John Lively, who faces Ryan RhoadsApril 27, 2024 | yahoo.comMotorcyclists reminded to have proper training before hitting the open roadApril 26, 2024 | news.yahoo.com3 Coachella Valley restaurants get 'B' inspection grades over food temps, vermin sightingsApril 26, 2024 | msn.comVaryaa Creations IPO allotment to be finalised today: Here's how to check allotment status as focus shifts to listingApril 26, 2024 | msn.comWV Dept. of Health monitoring measles following recent caseApril 26, 2024 | yahoo.comColumbia State hosts spring leadership for Operational Excellence Program receptionApril 26, 2024 | finance.yahoo.comBragg Gaming Group to Release First Quarter 2024 Results on May 9April 26, 2024 | msn.comAdvanced insulin pumps enhance blood sugar management in type 1 diabetesApril 26, 2024 | msn.comWhen the NFL draft is over: Steps to take if a flight home will not take off as scheduledApril 26, 2024 | msn.comJNK India IPO allotment status: Check application, latest GMP and listing dateApril 25, 2024 | msn.comNorCal Celtic and California Honey Festivals return to Woodland | Just BusinessApril 25, 2024 | msn.comLANE CLOSURES: LA 15 in Monroe, Ouachita Parish, to have ongoing construction on April 29thApril 25, 2024 | tmcnet.comCegedim achieves solid growth in first quarter 2024April 25, 2024 | msn.comPrenatal opioid exposure not associated with risk of neuropsychiatric disorders in childrenSee More Headlines Receive ASPX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ASPX) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/16/2015Today4/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ASPX CUSIPN/A CIK1454189 WebN/A Phone+1-858-5582400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report ASPX Stock Analysis - Frequently Asked Questions How were (ASPX)'s earnings last quarter? (ASPX) (NASDAQ:ASPX) released its quarterly earnings results on Monday, March, 16th. The biopharmaceutical company reported ($0.74) EPS for the quarter, missing analysts' consensus estimates of ($0.59) by $0.15. What other stocks do shareholders of (ASPX) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (ASPX) investors own include Achillion Pharmaceuticals (ACHN), Alnylam Pharmaceuticals (ALNY), GoPro (GPRO), Ambarella (AMBA), Alkermes (ALKS), Align Technology (ALGN), Akebia Therapeutics (AKBA), Agios Pharmaceuticals (AGIO), ACADIA Pharmaceuticals (ACAD) and Arbutus Biopharma (ABUS). This page (NASDAQ:ASPX) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsTruth about Trump you’ve never heardPorter & CompanyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmith4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ASPX) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
